Skip to content

A Randomized Trial for Suicidal Patients

Collaborative Assessment and Management of Suicidality (CAMS) in Comparison to Treatment as Usual (TAU) for Suicidal Patients: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02685943
Enrollment
80
Registered
2016-02-19
Start date
2015-04-01
Completion date
2019-10-01
Last updated
2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attempted Suicide, Suicidal Ideation, Suicide

Brief summary

Although suicide risk is highly prevalent among the patient population in mental health care, remarkably little research exists on effective treatments. Among a small set of novel approaches, CAMS is particularly promising. The investigators compare CAMS to TAU in a randomized controlled trial at four departments in Vestre Viken Hospital Trust, hypothesizing CAMS to be the superior approach. Primary outcome measures are suicidal ideation and suicide attempts, with secondary outcome measures including general symptoms of mental health problems. Changes in the outcome measures are compared between the two groups from baseline to 6 and 12 months after patients are included in the study. The study has the potential to impact the science of treating suicidal individuals and it could benefit the general public by establishing CAMS as an effective clinical approach for rapidly reducing suicide risk.

Interventions

BEHAVIORALPsychotherapy

Sponsors

The Catholic University of America
CollaboratorOTHER
Helse Sor-Ost
CollaboratorOTHER_GOV
Norwegian Institute of Public Health
CollaboratorOTHER_GOV
Vestre Viken Hospital Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Months to No maximum
Healthy volunteers
No

Inclusion criteria

* Significant suicide ideation on Beck's Scale for Suicide Ideation (score 13 and above). Informed consent to participate.

Exclusion criteria

* Active psychosis, cognitive or physical impairment or other problems that preclude the ability to understand the study procedures and provide informed consent, non-Norwegian speaking subjects

Design outcomes

Primary

MeasureTime frameDescription
Changes in scores on Beck's Scale for Suicide Ideation (BSSI)From baseline to 6 and 12 months after patient is included in the studyInterview scale with 19 items that measures a patient's suicidal ideation at its worst point in the past 2 weeks.

Secondary

MeasureTime frameDescription
Changes in scores on The Outcome Questionaire 45 (OQ-45)From baseline to 6 and 12 months after patient is included in the studyA 45-item questionnaire designed to measure key areas of mental health functioning (symptoms, interpersonal problems and social role functioning)
Norwegian Patient Registry (NPR) dataYearly for five years after study inclusionData entered in the NPR on self harm, suicide attempts, new hospital admissions to health treatments, discharge diagnosis, intoxication, and death by any causes.
Changes in scores on Suicide Attempt Self-Injury Count (SASI-C)changes from baseline to 6 and 12 months after patient is included in the studyAn interview covering past self-inflicted injuries and categorizing them into suicide attempts and non-suicidal acts. The tool also creates counts of self-inflicted injuries by method, medical risk severity and lethality

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026